University Hospital of Alexandroupolis
Alexandroupoli, Evros, 68100, Greece
NCT Number: NCT04263636
Primary objective of this study is to construct and validate a modified luminous efficiency function that addresses the distinct total eye light transmittance of patients that underwent bilateral pseudophakic presbyopic correction with trifocal intraocular lenses (IOLs) implantations.
Looking for future studies?
Notify Me45 year–70 year
All sexes
Observational
Alexandroupoli, Evros, 68100, Greece
Present study aims to identify in which degree multifocal IOLs modify eye light transmission and estimate the necessary task and environmental lighting adjustment in order to address lighting needs of patients following bilateral pseudophakic presbyopic corrections. Specifically, the aim of this study is to identify the minimum light intensity in which patients that underwent pseudophakic presbyopic correction with trifocal IOLs can reach their maximum visual acuity (measured when lights are at the 100% lighting level)
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Uneventful bilateral pseudophakic presbyopic correction with trifocal diffractive IOLs
Time frame: 6 months postoperatively
Minimum light intensity in which participants reach their maximum critical visual acuity
Time frame: 6 months postoperatively
The print size of the optotype line fulfilling this criterion: all of the following lines are read at a time that is 1.96 times the standard deviation over the average reading time of the larger preceding lines. In clinical practice, the CVA is the minimum VA that can be read with the maximum possible speed.
Democritus University of Thrace
Other
Introduction of a Modified Luminous Efficiency Function V(λ)' That Addresses Total Light Transmittance of Patients That Underwent Pseudophakic Presbyopic Corrections
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07723716
Eye Diseases, Presbyopia
Seoul, South Korea
View Trial DetailsNCT05646719
Eye Diseases, Presbyopia
Phoenix, Arizona, United States
View Trial DetailsNCT07076160
Eye Diseases, Presbyopia
Jacksonville, Florida, United States
View Trial DetailsNCT07570602
Eye Diseases, Presbyopia
Bloomington, Indiana, United States
View Trial Details